Influence of inoculum, medium and serum on the in-vitro susceptibility of coagulase-negative staphylococci to teicoplanin and vancomycin

Journal of Antimicrobial Chemotherapy

Volumn 37, Issue 6, 1996, Pages 1103-1109

  Kennedy, H F ^a   Seal, D V ^a,b  

^a ROYAL HOSPITAL FOR SICK CHILDREN   (United Kingdom)

^b WESTERN INFIRMARY   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

POLYPEPTIDE ANTIBIOTIC AGENT; TEICOPLANIN; VANCOMYCIN;

ANTIBACTERIAL ACTIVITY; ANTIBIOTIC SENSITIVITY; ARTICLE; CATHETER; COAGULASE NEGATIVE STAPHYLOCOCCUS; MINIMUM INHIBITORY CONCENTRATION; NONHUMAN; SERUM;

ANIMALS; ANTI-BACTERIAL AGENTS; BLOOD PROTEINS; CELL DIVISION; COAGULASE; CULTURE MEDIA, SERUM-FREE; HORSES; MICROBIAL SENSITIVITY TESTS; STAPHYLOCOCCUS; TEICOPLANIN; VANCOMYCIN;

EID: 0029736716     PISSN: 03057453     EISSN: None     Source Type: Journal    
DOI: 10.1093/jac/37.6.1103     Document Type: Article

References (21)

1. Anton, A. H. (1960). The relation between the binding of sulfonamides to albumin and their antibacterial efficacy. Journal of Pharmacology and Experimental Therapeutics 129, 282-90.
2. Assandri, A. & Bernareggi, A. (1987). Binding of teicoplanin to human serum albumin. European Journal of Pharmacology 33, 191-5.
3. Barr, J. & Tillement, J.-P. (1989). Protein binding of antimicrobials: questions to be answered. In Focus on Coagulase Negative Staphylococci, (Phillips, I., Ed.), pp. 81-93. Royal Society of Medical Services Limited, London.
4. Borghi, A., Coronelli, C., Faniuolo, L., Allievi, G., Pallanza, R. & Gallo, G. G. (1984). Teichomycins, new antibiotics from Actinoplanes teichomyceticus nov. sp. IV. Separation and characterisation of the components of teichomycin (teicoplanin). Journal of Antibiotics 37, 615-20.
5. Davey, P. G. & Williams, A. H. (1991). A review of the safety profile of teicoplanin. Journal of Antimicrobial Chemotherapy 27, Suppl. B, 69-73.
6. Felmingham, D. (1993). Towards the ideal glycopeptide. Journal of Antimicrobial Chemotherapy 32, 663-6.
7. Felmingham, D., Solomonides, K., O'Hare, M. D., Wilson, A. P. R. & Grüneberg, R. N. (1987). The effect of medium and inoculum on the activity of vancomycin and teicoplanin against coagulase negative Staphylococci. Journal of Antimicrobial Chemotherapy 20, 609-10.
8. Krogstad, D. J., Moellering, R. C. & Greenblatt, D. J. (1980). Single-dose kinetics of intravenous vancomycin. Journal of Clinical Pharmacology 20, 197-201.
9. Kunin, C. M. (1966). Clinical pharmacology of the new penicillins. I. The importance of serum protein binding in determining antimicrobial activity and concentration in serum. Clinical Pharmacology and Therapeutics 7, 166-79.
10. MacGowan, A. P., McMullin, C. M., White, L. O., Reeves, D. S., Davis, E. & Speller, D. C. E. (1992). Serum monitoring of teicoplanin. Journal of Antimicrobial Chemotherapy 30, 399-402.
11. Merrikin, D. J., Briant, J. & Rolinson, G. N. (1983). Effect of protein binding on antibiotic activity in vivo. Journal of Antimicrobial Chemotherapy 11, 233-8.
12. National Committee for Clinical Laboratory Standards. (1991). Performance Standards for Antimicrobial Susceptibility Testing. Document M 100-S3. Third Informational Supplement. NCCLS, Villanova, PA.
13. Peters, G., von Eiff, C. & Herrmann, M. (1995). The changing pattern of coagulase-negative staphylococci as infectious pathogens. Current Opinion in Infectious Diseases 8, Suppl. 1, S12-19.
14. Raad, I. I. & Bodey, G. P. (1992). Infectious complications of indwelling vascular catheters. Clinical Infectious Diseases 15, 197-208.
15. Rowland, M. (1990). Clinical pharmacokinetics of teicoplanin. Clinical Pharmacokinetics 18, 184-209.
16. Smith, S. R., Cheesbrough, J., Spearing, R. & Davies, J. M. (1989). Randomized prospective study comparing vancomycin with teicoplanin in the treatment of infections associated with Hickman catheters. Antimicrobial Agents and Chemotherapy 33, 1193-7.
17. Somma, S., Gastaldo, L. & Corti, A. (1984). Teicoplanin, a new antibiotic from Actinoplanes teichomyceticus nov. sp. Antimicrobial Agents and Chemotherapy 26, 917-23.
18. Williams, A. H. & Grüneberg, R. N. (1984). Teicoplanin. Journal of Antimicrobial Chemotherapy 14, 441-5.
19. Wilson, A. P. R., Grüneberg, R. N. & Neu, H. (1993). Dosage recommendations for teicoplanin. Journal of Antimicrobial Chemotherapy 32, 792-6.
20. Wise, R. (1986). The clinical relevance of protein binding and tissue concentrations in antimicrobial therapy. Clinical Pharmacokinetics 11, 470-82.
21. Working Party of the British Society for Antimicrobial Chemotherapy. (1991). A guide to sensitivity testing. Journal of Antimicrobial Chemotherapy 27, Suppl. D.